Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Type
(
1 selected
)
Type
Guidance (7)
Guidance programme
Guidance programme
Health technology evaluations (1)
Highly specialised technologies guidance (1)
Interventional procedures guidance (2)
Technology appraisal guidance (3)
Apply filters
Showing 1 to 7 of 7
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour
Interventional procedure consultation
Interventional procedures guidance
19 December 2024
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessment
Draft guidance
Health technology evaluation
17 December 2024
Molnupiravir for treating COVID-19 [ID6340]
Draft guidance
Technology appraisal guidance
17 December 2024
Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease
Interventional procedure consultation
Interventional procedures guidance
12 December 2024
Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130]
Evaluation consultation
Highly specialised technology
12 December 2024
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
Draft guidance
Technology appraisal guidance
5 December 2024
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887]
Draft guidance
Technology appraisal guidance
5 December 2024
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top